Atjaunināt sīkdatņu piekrišanu

E-grāmata: Oxidative Stress in Heart Diseases

Edited by , Edited by , Edited by , Edited by
  • Formāts: EPUB+DRM
  • Izdošanas datums: 06-Nov-2019
  • Izdevniecība: Springer Verlag, Singapore
  • Valoda: eng
  • ISBN-13: 9789811382734
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 261,13 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Izdošanas datums: 06-Nov-2019
  • Izdevniecība: Springer Verlag, Singapore
  • Valoda: eng
  • ISBN-13: 9789811382734
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book bridges the gap between fundamental and translational research in the area of heart disease. It describes a multidisciplinary approach, and demonstrates biochemical mechanisms associated with dysregulation of redox signaling, which leads heart disease. Presenting recent  studies on improved forms of ROS scavenging enzymes; specific inhibitors for different ROS generating enzymes; and oxidant induced signaling pathways and their antagonists that allow subtle modulation of redox signaling,  it also discusses the spatial and temporal aspects of oxidative stress in the cardiovascular system, which are of vital importance in developing better strategies for treating heart disease. Each chapter offers researchers valuable insights into identifying targets for drug development for different types of heart disease.


I. Role of Oxidative Stress in Heart Diseases.- 1. J.L Johnson.
Laboratory of cardiovascular pathology, School of Clinical Sciences,
University of Bristol, Bristol. UK.- 2. M.A.Srivastava, Department of
Physiology, McGill University, Canada.- 3. P. Balakumar. Pharmacology Unit,
AIMST University, Semeling 08100 Bedong, Kedah Darul Aman, Malaysia.- 4. K. B
Pasumarthi. Department of Pharmacology, Dalhousie University, Halifax, Nova
Scotia, Canada.-
5. B. Turan. Department of Biophysics, Ankara University,
Faculty of Medicine, Ankara,Turkey.-
6. Z. Xie. Marshall Institute of
Interdisciplinary Research, Marshall University, Huntington,WV, USA.-
7. T.
L. Haas. Angiogenesis Research Group, School of Health Sciences, York
University,Toronto, Canada.-
8. A. Kukol. School of Life and Medical
Sciences, University of Hertfordshire, Hatfield, UK.-
9. N.S.Dhalla,
Cardiovascular Research Institute, University of Manitoba, Winnipeg, Canada.-
10. A.K.Srivastava. Cell Signalling laboratory, McGill University, Canada.-
11. S.Chakraborti, University of Kalyani, Kalyani 741235, West Bengal,
India.-
12. S.Goswami, School of Life Sciences, Jawaharlal Nehru University,
New Delhi, India.-
13. C.C.Kartha, Rajiv Gandhi Institute of Biotechnology,
Thiruvanatapuram, India.-
14. S.K.Malick, Department of Pharmacology. AIIMS,
New Delhi, India.-
15. S.Chatterjee, Anna University, Chennai, India.-
16.
N.Mahapatra, IIT-Madras, Chennai, India.-
17. R. Bhunya, Department of
Biochemistry and Biophysicvs, University of kalyani, West Bengal, India.-
18.
S.Nandi, North Est Hill University, Meghalaya, India.-
19. N.K.Ganguly, Sir
gangaram Hospital, New Delhi.-
20. M.Dixit, CSIR-CDR, -Lucknow, India.-
21.
A.D.Abell, University of Adelaide, Australia.-
22. Chava Kimchi Sarfaty,
Centre for Biologics Evaluation and Research, Foodand Drug Administration,
Bethesda, Maryland, USA.-
23. B. Furhman, Technion Faculty of Medicine and
Ramban Medical Center, Hiafa, Israel.-
24. R.F.Gerlach, Department of
Physiology, University of Sao Paulo, Brazil.- 25.T.L.Haas, School of
Kinesiology and Health Sciences, York University, Toronto, Canada.-
26. B.
Mittal, Department of Genetics. Sanjay Gandhi Post Graduate Institute of
Medical Sciences, Lucknow, Uttap Pradesh, India.-
27. Richard Schulz,
Department of Pedfiatrics, University of Alberta, Canada.-
28. Bodh J
Jugdutt, Mackenzie Haeth Sciences Centre, Division of Cardiology, University
of Alberta, Canada.-
29. Vibha Rani, Jaypee Institute of Information
Technology, Noida, Uttar Pradesh, India .-
34. Veena Dhawan, Department of
Experimental Medicine and Biotechnology,PGIMER,Chandigarh, India.-
30.
Surekha Rani, Department of Genetics, Osmania University, Hyderabad,
Telengana State, India.
Dr. Sajal Chakraborti (e.mail: saj_chakra@rediffmail.com) is a senior Professor of Biochemistry at the University of Kalyani, West Bengal, India. His research mainly focuses on the role of vasoactive agents in regulating vascular tone under oxidant and calcium signaling phenomena. He has been engaged in biochemistry teaching and research for the past 40 years.





 Dr. Naranjan S Dhalla (e.mail: NSDhalla@sbrc.ca) is a distinguished Professor at the University of Manitoba, Winnnipeg, Canada. His expertise includes the subcellular and molecular basis of heart function in health and disease. He has been involved in multidisciplinary research and education to promote the scientific basis of cardiology for over 50 years. 





Dr. Madhu Dixit (e.mail: rmadhudikshit@gmail.com) is a National Chair Fellow of the Translational Health Science and Technology Institute, Faridabad, Haryana, India. She has contributed to the general area of biochemical pharmacology and has a special interest in cardiovascular pharmacology, particularly redox biology.  Dr. Dikshit has been involved in research, especially drug discovery and development, for over 40 years.





Dr. Nirmal K Gangul, (e-mail: ganguly1nk@gmail.com), is a distinguished biotechnologist and former Director General of the Indian Council of Medical Research (ICMR), and is associated with Global Health Strategies, New Delhi, India. He was presented with the Padma Bhushan Award in the field of Medicine by the President of India in 2008.